The expanding scenario of advanced non-small-cell lung cancer between emerging evidence and clinical tasks

Andrea De Giglio; Biagio Ricciuti; Giulio Metro

doi:10.7573/dic.2022-11-4

The expanding scenario of advanced non-small-cell lung cancer between emerging evidence and clinical tasks

Drugs Context. 2023 May 2:12:2022-11-4. doi: 10.7573/dic.2022-11-4. eCollection 2023.

Authors

Andrea De Giglio^{1

2}, Biagio Ricciuti³, Giulio Metro⁴

Affiliations

¹ Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
² Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
³ Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
⁴ Medical Oncology, Santa Maria Della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy.

Abstract

This Editorial by De Giglio, Ricciuti and Metro introduces the series Treatment of advanced non-small-cell lung cancer: one size does not fit all: https://www.drugsincontext.com/special_issues/treatment-of-advanced-non-small-cell-lung-cancer-one-size-does-not-fit-all/.

Keywords: immunotherapy; non-small-cell lung cancer; personalized medicine; targeted therapy.

Publication types

Editorial